Prevent an increase in the proportion of nontyphoidal Salmonella infections that are resistant to multiple drug classes — FS‑05 Data

Status: Baseline only

  Baseline only

Most Recent Data:
10.6 percent (2015-17)

Target:
10.6 percent

Desired Direction:
Maintains

Baseline:
10.6 percent of nontyphoidal Salmonella infections in humans were resistant to 3 or more drug classes in 2015-17

Show disparities data *

Show disparities data *
Non-typhoidal Salmonella from humans resistant to 3+ classes of antimicrobial agents
(percent), 2015-17
Population 2015-17
Total
10.6